Results 1 to 10 of about 198,125 (333)

Low molecular-weight heparin is better than warfarin for prevention of recurrent venous thromboembolism in cancer patients [PDF]

, 2017
A critical appraisal and clinical application of Lee AYY, Levin MN, Bake RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
Choi, Sarah
core   +3 more sources

Low molecular weight heparin-induced thrombocytopenia management during hemodialysis and cardiac surgery: a case report and literature review [PDF]

JA Clinical Reports
Background Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy, including low molecular weight heparins (LMWHs) like dalteparin.
Shuto Takada, Shogo Suzuki, Takahiro Tamura   +2 more
doaj   +2 more sources

Comparing survival with vitamin K antagonists, low-molecular-weight heparin, and direct oral anticoagulants in patients with cancer-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xirou V, Patel A, Altamirano MFA, Singh R, Gusdorf J, Barnum K, McNichol M, Ryu J, Zwicker JI, Chiasakul T, Patell R.   +10 more
europepmc   +2 more sources

Poly(dimethylsiloxane)-poly(ethyleneoxide)-heparin block copolymers. I. Synthesis and characterization [PDF]

, 1988
Amphiphilic block copolymers containing poly(dimethylsiloxane), poly(ethylene oxide), and heparin (PDMS-PEO-Hep) have been prepared via a series of coupling reactions using functionalized prepolymers, diisocyanates, and derivatized heparins.
Agarwal, Atkinson, Bara, Barrowcliffe, Bjork, Borsch, Breuker, Carlton, Danishefsky, Danishefsky, Dumelow, Ebert, Ebert, Grainger, Hennink, Hoffman, Hughes, Kossmehl, Kossmehl, Kurzer, Lane, Lyman, Miura, Mori, Okano, Okano, Okano, Okano, Okano, Piepkorn, Plueddeman, Quast, Rich, Smith, Solomon, Tezuka, Thunberg, Torchilin, Vulic, Yamashita, Yilgor   +40 more
core   +21 more sources

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin [PDF]

Journal of the Serbian Chemical Society, 2009
The interaction between trypsin, a prototype S1 serine protease, with heparin and its low molecular weight derivative dalteparin were investigated. Direct inhibition of the proteolytic activity of trypsin by heparin and dalteparin, used in concentrations
OLIVERA M. BOSNIĆ, KRISTINA R. GOPČEVIĆ, MIROSLAV M. VRVIĆ, IVANKA M. KARADŽIĆ   +3 more
doaj   +3 more sources

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era

American Heart Journal Plus, 2023
Unfractionated heparin (UFH) is commonly used for several life-threatening conditions requiring anticoagulant therapy but failure to reach therapeutic levels in 24 h can be associated with adverse outcomes.
Kayla Torppey, Marc Cohen, Manpreet Kaur, Natale Wasef, Aanchal Wats, Sumit Sohal, Gautam Visveswaran, Sandra Richardson   +7 more
doaj   +1 more source

Low molecular weight heparin in COVID-19: benefits and concerns

Frontiers in Pharmacology, 2023
Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health.
Adham Makarem, Adham Makarem, Rana Zareef, Joseph Abourjeili, Joseph E Nassar, Fadi Bitar, Fadi Bitar, Fadi Bitar, Mariam Arabi, Mariam Arabi, Mariam Arabi   +10 more
doaj   +1 more source

The Effect of Low Molecular Weight Heparins on Placentation: A Rat Model Study

Cumhuriyet Science Journal, 2022
Low molecular weight heparins (LMWHs) have been used for the treatment for recurrent pregnancy loss (RPL) for a long time. We aimed to investigate the efficacy of the LMWHs on angiogenesis and apoptosis during placentation.
Gülizar Özer, Çağlar Yıldız, Hatice Özer, Ali Çetin   +3 more
doaj   +1 more source

Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination [PDF]

, 2014
Rationale: Preeclampsia is a devastating medical complication of pregnancy which leads to maternal and fetal morbidity and mortality. While the etiology of preeclampsia is unclear, human and animal studies suggest that excessive circulating levels of ...
Hagmann, Henning, Bossung, Verena, Belaidi, Abdel Ali, Fridman, Alexander, Karumanchi, S. Ananth, Thadhani, Ravi, Schermer, Bernhard, Mallmann, Peter, Schwarz, Guenter, Benzing, Thomas, Brinkkoetter, Paul T.   +10 more
core   +8 more sources

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review

Archives of Medical Science, 2021
Introduction The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to ...
Chunfeng Wu, Liling Li, Jiarong Zhang, Yang Song   +3 more
doaj   +1 more source